Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Elite Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ELTP
Over the counter
2834
https://www.elitepharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Elite Pharmaceuticals Inc
Elite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcript
- Feb 16th, 2024 3:29 pm
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
- Feb 14th, 2024 9:30 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
- Feb 8th, 2024 1:15 pm
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant
- Dec 26th, 2023 12:00 pm
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC
- Dec 12th, 2023 12:00 pm
Elite Pharmaceuticals, Inc. (PNK:ELTP) Q2 2024 Earnings Call Transcript
- Nov 20th, 2023 6:54 pm
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
- Nov 14th, 2023 10:35 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023
- Nov 10th, 2023 4:30 pm
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
- Sep 25th, 2023 10:00 am
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
- Sep 7th, 2023 10:00 am
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
- Aug 28th, 2023 10:00 am
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information
- Aug 14th, 2023 8:45 am
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023
- Aug 9th, 2023 11:00 am
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information
- Jun 29th, 2023 9:10 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023
- Jun 22nd, 2023 10:00 am
Scroll